近日美敦力全球高级副总裁及大中华区总裁顾宇韶在接受专访时说我们认为中国正成为全球医疗创新的重要策源地。在不久的将来中国会成为全球体量最大的医疗器械市场。“医疗器械的创新需要AI赋能广泛服务于脑机接口、机器人、图像识别等领域因此我们积极与中国本土AI公司展开合作。”顾宇韶直言短短十年间中国医疗器械行业从早期的跟随式创新迅速发展到能做出改进式创新甚至迭代出全球首创技术创新生态加速成熟。2025年底美敦力在北京运营首个数字化医疗创新基地期望连接产业链伙伴、科研机构与临床探索数智医疗创新模式。。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.